ETD Collection

Permanent URI for this collectionhttps://wiredspace.wits.ac.za/handle/10539/104


Please note: Digitised content is made available at the best possible quality range, taking into consideration file size and the condition of the original item. These restrictions may sometimes affect the quality of the final published item. For queries regarding content of ETD collection please contact IR specialists by email : IR specialists or Tel : 011 717 4652 / 1954

Follow the link below for important information about Electronic Theses and Dissertations (ETD)

Library Guide about ETD

Browse

Filters

20191

Settings

Author: search.filters.author.Khan, Shaida BibiSubject: search.filters.subject.Tomography

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    Determination of the calcaemic status of oncology patients at the Charlotte Maxeke Johannesburg academic hospital, using unadjusted serum total calcium
    (2019) Khan, Shaida Bibi
    Background: When total serum calcium (TCa) is used to determine the calcaemic status of patients, it has to be adjusted, using one of several formulae to limit the effect of low or raised serum albumin levels. All the existing adjustment formulae, were not validated against ionised calcium, neither have they been adjusted for the presence of paraproteins. They have also not been validated for use in cancer patients complicated with chronic kidney disease and cachexia. This study therefore aimed to determine whether unadjusted serum TCa measurement, could be used successfully to determine the calcaemic status instead of the gold standard, ionised calcium (ICa), in two sub-groups of hospital patients with breast cancer (BCA) and multiple myeloma (MM). Material and methods: 202 paired TCa/ICa data points for MM and 3 467 for BCA were reviewed retrospectively over a 1-year period for diagnostic concordance and discordance using ICa as the gold standard. Results: In the MM sub-group, the diagnostic concordance was 60.1% (18 - 59 years) and 78.8% (60 - 90 years) for hypocalcaemia, and 7.4% (18-59 years) and 42.9% (60 -90 years) for hypercalcaemia. Whilst in the BCA sub-group, the diagnostic concordance was 46.1% (18 - 59 years) and 44.5% (60 - 90 years) for hypocalcaemia, and 14.7% (18-59 years) and 21.5% (60 -90 years) for hypercalcaemia. Conclusion: In all cancer sub-groups, both hypocalcaemia and hypercalcaemia were underestimated to various degrees. This was similar to other studies published in non-cancer- specific patients. The poor performance of unadjusted TCa in the study prompted a recommendation that ICa should be used preferentially in cancer patients.